---
title: "Citi downgrades Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) to a Hold"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292541573.md"
description: "Citi analyst Laura Sutcliffe downgraded ResMed Inc CHESS Depositary Interests to a Hold with an A$34.00 price target. This follows Morgan Stanley's mixed ratings, maintaining a Buy while David Bailey issued a Hold on July 8. Sutcliffe, covering the Healthcare sector, has a 52.05% success rate."
datetime: "2026-07-13T23:45:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292541573.md)
  - [en](https://longbridge.com/en/news/292541573.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292541573.md)
---

# Citi downgrades Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) to a Hold

Citi analyst Laura Sutcliffe downgraded Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh to a Hold today and set a price target of A$34.00.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

According to TipRanks, Sutcliffe is a 3-star analyst with an average return of 1.7% and a 52.05% success rate. Sutcliffe covers the Healthcare sector, focusing on stocks such as Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, CSL, and Telix Pharmaceuticals.

In addition to Citi, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh also received a Hold from Morgan Stanley’s David Bailey in a report issued on July 8. However, on the same day, Morgans maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (ASX: RMD).

### Related Stocks

- [RMD.US](https://longbridge.com/en/quote/RMD.US.md)
- [RMD.AU](https://longbridge.com/en/quote/RMD.AU.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [CSL.AU](https://longbridge.com/en/quote/CSL.AU.md)
- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)
- [TLX.US](https://longbridge.com/en/quote/TLX.US.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)
- [CSLLY.US](https://longbridge.com/en/quote/CSLLY.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [ResMed beats on earnings and ups dividend, yet shares plummet](https://longbridge.com/en/news/295180735.md)
- [ResMed Q4 FY26 GAAP diluted EPS rises 2% to $2.64; revenue increases 9% to $1.46 billion](https://longbridge.com/en/news/295140984.md)
- [ResMed announces dividend of R$ 0.57 per unit, payable Sept. 30](https://longbridge.com/en/news/295267898.md)
- [ResMed director Peter C. Farrell disposes of 8,000 common shares worth $1.8 million](https://longbridge.com/en/news/295133419.md)
- [Royal Bank of Canada Reduces Stock Holdings in ResMed Inc. $RMD](https://longbridge.com/en/news/294602242.md)